The study conducted by Yoshimoto et al. presented a mechanism of upregulation of MCL-1 anti-apoptotic protein in FLT3–ITD AML via STAT5 activation, making it a possible pathway for mediating the resistance [98]. This evidence concerns the gene MCL1 and acute myeloid leukemia.